WCN26-4124 CITRATE VERSUS HEPARIN LOCK IN HEMODIALYSIS CATHETER'S COMPLICATIONS; A PILOT UNICENTER STUDY

Read full text Summarise with VIRAT
Authors: Edgar Montoya, Oscar Alberto Nava, Kriscia Mariela Hernandez Arteaga, María José González, Sergio Pérez, Noel Gúzman, Enrique Montoya, Oggun Cano, Katia Miranda
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Citrate lock and heparin lock are the two principal intraluminal agents used to maintain central venous catheter (CVC) patency and reduce complications in hemodialysis patients. Heparin, traditionally, acts as an anticoagulant to prevent catheter thrombosis but carries a risk of systemic anticoagulation and bleeding if inadvertently flushed into the circulation. Citrate, provides local anticoagulation by chelating calcium and also exhibits antimicrobial properties, with minimal systemic effects.

Fields of Study & Subjects

Central Venous Catheters and Hemodialysis Dialysis and Renal Disease Management Parathyroid Disorders and Treatments

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105233–105233
Publication date
25 March 2026
Language
EN